Feasibility of a Symptomatic Screening Program for Early Detection of Gastric Cancer in Roatán, Honduras.

IF 3.2 Q2 ONCOLOGY
JCO Global Oncology Pub Date : 2025-05-01 Epub Date: 2025-05-22 DOI:10.1200/GO-24-00574
Jade Tso, Susana Galeas, Brendalee Martinez, Kallie Vallecillo, Mustafa Faleh Abidalhassan, Natan Webster, Heidy Leiva, Mustafa Al-Qaraghli, Cameron Gaskill
{"title":"Feasibility of a Symptomatic Screening Program for Early Detection of Gastric Cancer in Roatán, Honduras.","authors":"Jade Tso, Susana Galeas, Brendalee Martinez, Kallie Vallecillo, Mustafa Faleh Abidalhassan, Natan Webster, Heidy Leiva, Mustafa Al-Qaraghli, Cameron Gaskill","doi":"10.1200/GO-24-00574","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Gastric cancer (GC) is a leading cause of cancer-related death in Central America, with late-stage diagnosis common because of nonspecific early symptoms. Symptomatic screening guidelines validated in high-income settings have been used to identify patients requiring urgent referral for upper GI endoscopy.</p><p><strong>Methods: </strong>This tool was piloted to assess feasibility for early detection of GC at a primary care clinic in Roatán, Honduras. If positive, a referral to endoscopy was placed, and patients contacted monthly for up to 4 months to collect information on demographics, GC risk factors, barriers to receiving endoscopy, and if they received an endoscopy. Provider questionnaires assessed endoscopy capacity and perceived patient barriers.</p><p><strong>Results: </strong>Five hundred patients were screened over 12 months. Nine screened positive, with seven clinically relevant to GC. Of these, four (57%) were female, average age was 49 years (IQR, 18), average number of years lived in Roatán was 29 (IQR, 34), and hypertension (57%) and hyperlipidemia (29%) were the most reported comorbidities. Two (29%) had a family history of cancer, four (57%) had a previous H. pylori infection, six (71%) took medication for acid reflux, and four (57%) had dietary risk factors for GC. All patients cited cost as a barrier to care, while two (29%) each reported difficulty traveling to a facility, lack of knowledge on which facilities did endoscopy, and uncertainty of whether they needed the procedure as other barriers.</p><p><strong>Conclusion: </strong>Although symptomatic screening guidelines are feasible for screening GC in Honduras, limitations in endoscopy access and capacity pose barriers to early diagnosis. These findings highlight the need to increase diagnostic capacity and address financial barriers to endoscopy.</p>","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":"11 ","pages":"e2400574"},"PeriodicalIF":3.2000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO Global Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1200/GO-24-00574","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/22 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Gastric cancer (GC) is a leading cause of cancer-related death in Central America, with late-stage diagnosis common because of nonspecific early symptoms. Symptomatic screening guidelines validated in high-income settings have been used to identify patients requiring urgent referral for upper GI endoscopy.

Methods: This tool was piloted to assess feasibility for early detection of GC at a primary care clinic in Roatán, Honduras. If positive, a referral to endoscopy was placed, and patients contacted monthly for up to 4 months to collect information on demographics, GC risk factors, barriers to receiving endoscopy, and if they received an endoscopy. Provider questionnaires assessed endoscopy capacity and perceived patient barriers.

Results: Five hundred patients were screened over 12 months. Nine screened positive, with seven clinically relevant to GC. Of these, four (57%) were female, average age was 49 years (IQR, 18), average number of years lived in Roatán was 29 (IQR, 34), and hypertension (57%) and hyperlipidemia (29%) were the most reported comorbidities. Two (29%) had a family history of cancer, four (57%) had a previous H. pylori infection, six (71%) took medication for acid reflux, and four (57%) had dietary risk factors for GC. All patients cited cost as a barrier to care, while two (29%) each reported difficulty traveling to a facility, lack of knowledge on which facilities did endoscopy, and uncertainty of whether they needed the procedure as other barriers.

Conclusion: Although symptomatic screening guidelines are feasible for screening GC in Honduras, limitations in endoscopy access and capacity pose barriers to early diagnosis. These findings highlight the need to increase diagnostic capacity and address financial barriers to endoscopy.

洪都拉斯Roatán早期发现胃癌的症状筛查方案的可行性。
目的:胃癌(GC)是中美洲癌症相关死亡的主要原因,由于非特异性早期症状,晚期诊断很常见。在高收入环境中验证的症状筛查指南已用于识别需要紧急转诊进行上消化道内镜检查的患者。方法:该工具在洪都拉斯Roatán初级保健诊所进行试点,以评估早期检测GC的可行性。如果呈阳性,则转诊至内镜检查,并每月联系患者长达4个月,以收集人口统计学信息、GC危险因素、接受内镜检查的障碍以及是否接受了内镜检查。提供者问卷评估内窥镜检查能力和感知到的患者障碍。结果:在12个月内筛选了500例患者。9例筛查阳性,7例临床与胃癌相关。其中,4例(57%)为女性,平均年龄为49岁(IQR, 18),平均居住年数为29岁(IQR, 34),高血压(57%)和高脂血症(29%)是报道最多的合并症。2例(29%)有癌症家族史,4例(57%)有幽门螺旋杆菌感染史,6例(71%)服用过胃酸反流药物,4例(57%)有胃癌的饮食危险因素。所有患者都认为费用是护理的障碍,而两名患者(29%)分别报告难以前往设施,缺乏对哪些设施进行内窥镜检查的知识,以及不确定他们是否需要该程序作为其他障碍。结论:尽管症状性筛查指南在洪都拉斯筛查胃癌是可行的,但内窥镜检查途径和能力的限制对早期诊断构成了障碍。这些发现突出了提高内窥镜诊断能力和解决经济障碍的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JCO Global Oncology
JCO Global Oncology Medicine-Oncology
CiteScore
6.70
自引率
6.70%
发文量
310
审稿时长
7 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信